These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy. Škrtić M; Cherney DZ Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):96-103. PubMed ID: 25470017 [TBL] [Abstract][Full Text] [Related]
12. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes. Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Chattipakorn SC; Chattipakorn N; Lungkaphin A Biomed Pharmacother; 2017 Oct; 94():176-187. PubMed ID: 28759755 [TBL] [Abstract][Full Text] [Related]
13. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment]. Girard J Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741 [TBL] [Abstract][Full Text] [Related]
14. Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs. Chrysant SG Drugs Today (Barc); 2017 Mar; 53(3):191-202. PubMed ID: 28447076 [TBL] [Abstract][Full Text] [Related]
16. The renal effects of SGLT2 inhibitors and a mini-review of the literature. Andrianesis V; Glykofridi S; Doupis J Ther Adv Endocrinol Metab; 2016 Dec; 7(5-6):212-228. PubMed ID: 28203358 [TBL] [Abstract][Full Text] [Related]
17. SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem. Jabbour SA Postgrad Med; 2014 Jan; 126(1):111-7. PubMed ID: 24393758 [TBL] [Abstract][Full Text] [Related]
18. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. DeFronzo RA; Norton L; Abdul-Ghani M Nat Rev Nephrol; 2017 Jan; 13(1):11-26. PubMed ID: 27941935 [TBL] [Abstract][Full Text] [Related]
19. Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects. de Leeuw AE; de Boer RA Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):244-55. PubMed ID: 27533948 [TBL] [Abstract][Full Text] [Related]
20. Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Santer R; Calado J Clin J Am Soc Nephrol; 2010 Jan; 5(1):133-41. PubMed ID: 19965550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]